These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26536590)

  • 1. Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.
    Akhtar S; Chandrasekhar B; Attur S; Dhaunsi GS; Yousif MH; Benter IF
    PLoS One; 2015; 10(11):e0141657. PubMed ID: 26536590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
    Akhtar S; Yousif MH; Dhaunsi GS; Chandrasekhar B; Al-Farsi O; Benter IF
    Br J Pharmacol; 2012 Mar; 165(5):1390-400. PubMed ID: 21806601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.
    Akhtar S; Yousif MH; Dhaunsi GS; Sarkhouh F; Chandrasekhar B; Attur S; Benter IF
    PLoS One; 2013; 8(6):e67813. PubMed ID: 23826343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
    Mugabe BE; Yaghini FA; Song CY; Buharalioglu CK; Waters CM; Malik KU
    J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
    Yousif MH; Dhaunsi GS; Makki BM; Qabazard BA; Akhtar S; Benter IF
    Pharmacol Res; 2012 Sep; 66(3):269-75. PubMed ID: 22580236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats.
    Touyz RM; Wu XH; He G; Salomon S; Schiffrin EL
    Hypertension; 2002 Feb; 39(2 Pt 2):479-85. PubMed ID: 11882594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes.
    Benter IF; Sarkhou F; Al-Khaldi AT; Chandrasekhar B; Attur S; Dhaunsi GS; Yousif MH; Akhtar S
    J Drug Target; 2015; 23(6):506-18. PubMed ID: 26114862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice.
    Ogata Y; Nemoto W; Yamagata R; Nakagawasai O; Shimoyama S; Furukawa T; Ueno S; Tan-No K
    Eur J Pain; 2019 Apr; 23(4):739-749. PubMed ID: 30421564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7) inhibits vascular calcification in rats.
    Sui YB; Chang JR; Chen WJ; Zhao L; Zhang BH; Yu YR; Tang CS; Yin XH; Qi YF
    Peptides; 2013 Apr; 42():25-34. PubMed ID: 23291307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport.
    Wong TP; Ho KY; Ng EK; Debnam ES; Leung PS
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E669-81. PubMed ID: 22811473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naked Polyamidoamine Polymers Intrinsically Inhibit Angiotensin II-Mediated EGFR and ErbB2 Transactivation in a Dendrimer Generation- and Surface Chemistry-Dependent Manner.
    Akhtar S; El-Hashim AZ; Chandrasekhar B; Attur S; Benter IF
    Mol Pharm; 2016 May; 13(5):1575-86. PubMed ID: 26985693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor.
    Bokemeyer D; Schmitz U; Kramer HJ
    Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D.
    Li F; Malik KU
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1043-54. PubMed ID: 15525798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.
    Zhang F; Li S; Song J; Liu J; Cui Y; Chen H
    Atherosclerosis; 2017 Jun; 261():90-98. PubMed ID: 28283184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ang-(1-7)/ MAS1 receptor axis inhibits allergic airway inflammation via blockade of Src-mediated EGFR transactivation in a murine model of asthma.
    El-Hashim AZ; Khajah MA; Babyson RS; Renno WM; Ezeamuzie CI; Benter IF; Akhtar S
    PLoS One; 2019; 14(11):e0224163. PubMed ID: 31675376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice.
    Nemoto W; Ogata Y; Nakagawasai O; Yaoita F; Tadano T; Tan-No K
    Eur J Pain; 2014 Nov; 18(10):1471-9. PubMed ID: 24733750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
    Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway.
    Bihl JC; Zhang C; Zhao Y; Xiao X; Ma X; Chen Y; Chen S; Zhao B; Chen Y
    Vascul Pharmacol; 2015 Oct; 73():115-123. PubMed ID: 26264508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
    Su Z; Zimpelmann J; Burns KD
    Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
    Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
    Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.